Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-02-01

Clinical Trial Update: Maintenance Therapy With Sunitinib or Observation in Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating maintenance therapy with sunitinib versus observation in metastatic pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sutent (sunitinib)

Snippet

Sponsor: IRCCS San Raffaele | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED